ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

METTL3 preferentially enhances non-m6A translation of epigenetic factors and promotes tumourigenesis

Wei, Xueju; Huo, Yue; Pi, Jingnan; Gao, Yufeng; Rao, Shuan; He, Manman; Wei, Qinglv; Song, Peng; Chen, Yiying; Lu, Dongxu; Song, Wei; Liang, Junbo; Xu, Lingjie; Wang, Haixia; Hong, Guolin; Guo, Yuehong; Si, Yanmin; Xu, Jiayue; Wang, Xiaoshuang; Ma, Yanni; Yu, Shuyang; Zou, Dongling; Jin, Jing; Wang, Fang*; Yu, Jia*南方医科大学; 四川大学; 厦门大学; 中国医学科学院; 重庆大学; 中国农业大学; 中国医学科学院北京协和医院; 1
Nature Cell Biology2022-8DOI: 10.1038/s41556-022-00968-y
46被引4阅读
引用收藏
分享

摘要

Wei et al. identify that cytoplasmic METTL3 interacts with PABPC1 to facilitate translation of epigenetic factor mRNAs without m(6)A modification to promote tumour progression, suggesting an m(6)A-independent mechanism for this methyltransferase. @@@ METTL3 encodes the predominant catalytic enzyme to promote m(6)A methylation in nucleus. Recently, accumulating evidence has shown the expression of METTL3 in cytoplasm, but its function is not fully understood. Here we demonstrated an m(6)A-independent mechanism for METTL3 to promote tumour progression. In gastric cancer, METTL3 could not only facilitate cancer progression via m(6)A modification, but also bind to numerous non-m(6)A-modified mRNAs, suggesting an unexpected role of METTL3. Mechanistically, cytoplasm-anchored METTL3 interacted with PABPC1 to stabilize its association with cap-binding complex eIF4F, which preferentially promoted the translation of epigenetic factors without m(6)A modification. Clinical investigation showed that cytoplasmic distributed METTL3 was highly correlated with gastric cancer progression, and this finding could be expanded to prostate cancer. Therefore, the cytoplasmic METTL3 enhances the translation of epigenetic mRNAs, thus serving as an oncogenic driver in cancer progression, and METTL3 subcellular distribution can assist diagnosis and predict prognosis for patients with cancer.

学科与关键词

关键词
ALTERED LOCALIZATIONSUBCELLULAR-LOCALIZATIONGENE-EXPRESSIONBINDING-PROTEINRNAM(6)APACKAGESET1
相关
加载中…
  • The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis
    Zhang, Hui-Min; Qi, Fei-Fei; Wang, Jun; Duan, Yuan-Yuan; Zhao, Li-Li; Wang, Yun-Dan; Zhang, Tong-Cun*; Liao, Xing-Hua*INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23(12): 6451.被引 6
  • RNA m6A methylation regulates dissemination of cancer cells by modulating expression and membrane localization of β-catenin
    Li, Jiexin; Xie, Guoyou; Tian, Yifan; Li, Wanglin; Wu, Yingmin; Chen, Feng; Lin, Yu; Lin, Xinyao; Au, Shannon Wing-Ngor; Cao, Jie*; He, Weiling*; Wang, Hongsheng*Molecular Therapy, 2022, 30(4): 1578-1596.被引 19
  • METTL3 Accelerates Breast Cancer Progression via Regulating EZH2 m6A Modification
    Hu, Shaojun; Song, Yang; Zhou, Yu; Jiao, Yu; Li, Guopeng*Journal of Healthcare Engineering, 2022, 2022: 5794422.被引 6
查看全部 →

发表信息

论文状态
公开发表
期刊
Nature Cell Biology
发表日期
2022-08
卷期
第 24 卷, 第 8 期
页码
1278-+
DOI
10.1038/s41556-022-00968-y
语言
ENGLISH
期刊等级
1区
成果收录
SCIE
资助标注
National Key Research and Development Program of China [2019YFA0801800, 2021YFA1102400, 2019YFA0111700]; National Natural Science Foundation of China [81530007, 31725013, 82022001, 81970103, 82100135, 82073129]; CAMS Innovation Fund for Medical Sciences [2021-I2M-1-019, 2021-I2M-1-040]; CAMS [2016GH310001, 2017-I2M-BR-04, 2018RC310013]; Medical Epigenetics Research Center, CAMS [2017PT31035]; Outstanding Youths Development scheme of Nanfang Hospital, Southern Medical University [2020J001]; Southern Medical University [2019YQPY006]; Fundamental Research Funds for the Core Facility [3332019001]

作者

  • W

    Wei, Xueju (第一作者)

    chinese acad med sci · 1 · xiamen univ · peking union med coll

  • H

    Huo, Yue

    chinese acad med sci · peking union med coll

查看全部 25 位作者收起作者
  • P

    Pi, Jingnan

    chinese acad med sci · peking union med coll

  • G

    Gao, Yufeng

    chinese acad med sci · peking union med coll

  • R

    Rao, Shuan

    southern med univ

  • H

    He, Manman

    chinese acad med sci · peking union med coll

  • W

    Wei, Qinglv

    chinese acad med sci · peking union med coll

  • S

    Song, Peng

    2 · chinese peoples liberat army gen hosp

  • C

    Chen, Yiying

    chinese acad med sci · peking union med coll

  • L

    Lu, Dongxu

    chinese acad med sci · peking union med coll

  • S

    Song, Wei

    chinese acad med sci · peking union med coll

  • L

    Liang, Junbo

    chinese acad med sci · peking union med coll

  • X

    Xu, Lingjie

    sichuan univ

  • W

    Wang, Haixia

    chongqing univ · chongqing canc inst

  • H

    Hong, Guolin

    1 · xiamen univ

  • G

    Guo, Yuehong

    chinese acad med sci · peking union med coll

  • S

    Si, Yanmin

    chinese acad med sci · peking union med coll

  • X

    Xu, Jiayue

    chinese acad med sci · peking union med coll

  • W

    Wang, Xiaoshuang

    chinese acad med sci · peking union med coll

  • M

    Ma, Yanni

    chinese acad med sci · peking union med coll

  • Y

    Yu, Shuyang

    china agr univ

  • Z

    Zou, Dongling

    chongqing univ · chongqing canc inst

  • J

    Jin, Jing

    chinese acad med sci · peking union med coll

  • W

    Wang, Fang (通讯)

    chinese acad med sci · peking union med coll

  • Y

    Yu, Jia (通讯)

    chinese acad med sci · peking union med coll

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417